Acadia Pharmaceuticals ACAD Earnings Call Transcripts

NASDAQ ACAD
$18.28 +1.78 (+10.79%)
At close: Nov 10, 2026 · 4:00 PM EST
9 earnings calls on file for Acadia Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Acadia Pharmaceuticals Q3 2026 Earnings Call

Nov 4, 2026 8,331 words · 36 min read
  • Al KildaniSenior Vice President, Investor Relations and Corporate Communications
  • Catherine Owen AdamsChief Executive Officer
  • Tom GarnerChief Commercial Officer
  • Sanjeev PathakSenior Vice President and Head of Clinical Development
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Acadia Pharmaceuticals Earnings Call Transcripts

Calls9
LatestNov 4, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2025

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 9 Acadia Pharmaceuticals transcripts Register to get access to Acadia Pharmaceuticals’s earnings call transcripts.